Abstract
Abnormalities in microRNA expression in tumor cells are widely used as a basis to develop novel therapeutic and diagnostic approaches in oncology. The former mostly aims to target oncogenic microRNAs or to restore expression of microRNAs with tumor suppressor properties in cancer cells. However recently another way of using specific microRNA loss in tumor cells has been suggested. The strategy relies on frequently lost in cancer cells but abundant in cell of normal tissues specific microRNAs, and aims to control unwanted expression of a gene essential for therapeutic action, either therapeutic transgene or essential for viral replication gene in oncolytic viruses, thus minimizing damage to normal tissues and improving safety of cancer gene therapy. Here, history of development and basic principles of the approach as well as current progress in the field are overviewed, with emphasis on benefits brought by the microRNA-based control of specificity for cancer gene therapy and emerging possibility of personification of treatment.
Current Cancer Therapy Reviews
Title:MicroRNAs in Cancer Gene Therapy: Another Look
Volume: 10 Issue: 3
Author(s): Igor V. Korobko
Affiliation:
Keywords: Cancer gene therapy; microRNA; tumor specificity.
Abstract: Abnormalities in microRNA expression in tumor cells are widely used as a basis to develop novel therapeutic and diagnostic approaches in oncology. The former mostly aims to target oncogenic microRNAs or to restore expression of microRNAs with tumor suppressor properties in cancer cells. However recently another way of using specific microRNA loss in tumor cells has been suggested. The strategy relies on frequently lost in cancer cells but abundant in cell of normal tissues specific microRNAs, and aims to control unwanted expression of a gene essential for therapeutic action, either therapeutic transgene or essential for viral replication gene in oncolytic viruses, thus minimizing damage to normal tissues and improving safety of cancer gene therapy. Here, history of development and basic principles of the approach as well as current progress in the field are overviewed, with emphasis on benefits brought by the microRNA-based control of specificity for cancer gene therapy and emerging possibility of personification of treatment.
Export Options
About this article
Cite this article as:
V. Korobko Igor, MicroRNAs in Cancer Gene Therapy: Another Look, Current Cancer Therapy Reviews 2014; 10(3) . https://dx.doi.org/10.2174/157339471003150212111836
DOI https://dx.doi.org/10.2174/157339471003150212111836 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications
Current Diabetes Reviews Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer Drugs PET Molecular Imaging of Hypoxia in Ischemic Stroke: An Update
Current Vascular Pharmacology The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Potential Role of Natural Compounds Against Skin Aging
Current Medicinal Chemistry Synthesis of 9-O-3-(1-piperazinyl/morpholinyl/piperidinyl)pentyl-berberines as Potential Antioxidant and Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Anti-Cancer Agents in Medicinal Chemistry FDG-PET Imaging in Large Vessel Vasculitis and Polymyalgia Rheumatica: A Personal View
Current Immunology Reviews (Discontinued) Review of Cell and Organ Printing Patents
Recent Patents on Biomedical Engineering (Discontinued) Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery
Anti-Cancer Agents in Medicinal Chemistry Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Subject Index to Volume 5
Current Drug Targets Polymeric Radiotracers in Nuclear Imaging
Current Drug Delivery MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery SAGE Application in the Study of Diabetes
Current Pharmaceutical Biotechnology The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry Quantum Dots in the Therapy: Current Trends and Perspectives
Mini-Reviews in Medicinal Chemistry Circulating Tumor Stem Cells as Biomarkers for Cancer Progression
Recent Patents on Biomarkers